Literature DB >> 32109921

Keloid and Hypertrophic Scar Formation, Prevention, and Management: Standard Review of Abnormal Scarring in Orthopaedic Surgery.

Gregory Grabowski1, Matthew J Pacana, Elliot Chen.   

Abstract

Keloid and hypertrophic scar formation after orthopaedic surgical closure is a complex issue. The nature and location of procedures maximize wound tension, leave foreign bodies, and diminish dermal supply, all potentiating keloid formation. There is little discussion regarding the pathophysiology and management of this recurrent problem in orthopaedic literature. Keloid formation is a fibroproliferative disorder resulting in extensive production of extracellular matrix and collagen, but prevention and treatment is poorly understood. Patient and surgical factors contributing to the development of this condition are discussed. The treatments include both medical and surgical therapies that work at a biologic level and attempt to produce a cosmetic and complication-free management strategy. Medical options that have been investigated include combinations of intralesional steroid therapy, laser therapy, and biologics. Preventive surgical closure and excision remain mainstays of treatment. Radiation therapy has also been used in refractory cases with mixed results. Despite medical therapies and surgical excision aimed at treating the resulting scar, recurrence rate is very high for all modalities that have been studied to this point. Future work is being done to better understand the pathophysiology leading to keloid and hypertrophic scar formation in an effort to find preventive methods as compared to treatment strategies.

Entities:  

Year:  2020        PMID: 32109921     DOI: 10.5435/JAAOS-D-19-00690

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  6 in total

1.  Pluronic F127-liposome-encapsulated curcumin activates Nrf2/Keap1 signaling pathway to promote cell migration of HaCaT cells.

Authors:  Quan Zhou; Xu Cai; Ying Huang; Youliang Zhou
Journal:  Mol Cell Biochem       Date:  2022-07-04       Impact factor: 3.396

2.  Feasibility of aponeurectomy in combination with perioperative 192Ir high dose rate brachytherapy for Dupuytren's disease.

Authors:  I Frank Ciernik; Philipp Goldschmidt; Markus Wösle; Jochen Winter
Journal:  Strahlenther Onkol       Date:  2021-09-07       Impact factor: 3.621

3.  Identification of a Diagnostic Signature and Immune Cell Infiltration Characteristics in Keloids.

Authors:  Yijun Xia; Youbin Wang; Yingjie Xiao; Mengjie Shan; Yan Hao; Lingyun Zhang
Journal:  Front Mol Biosci       Date:  2022-05-20

4.  Effects of Apremilast on Induced Hypertrophic Scar of Rabbits.

Authors:  D Nidhal Ghazy; A Rahmah Abu-Raghif
Journal:  Arch Razi Inst       Date:  2021-12-30

5.  Effect of THBS1 on the Biological Function of Hypertrophic Scar Fibroblasts.

Authors:  D Jiang; B Guo; F Lin; Q Hui; K Tao
Journal:  Biomed Res Int       Date:  2020-12-09       Impact factor: 3.411

Review 6.  Current Advances in RNA Therapeutics for Human Diseases.

Authors:  Hannah Zogg; Rajan Singh; Seungil Ro
Journal:  Int J Mol Sci       Date:  2022-03-01       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.